X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Lupin Ltd with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs DIVIS LABORATORIES - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN LTD DIVIS LABORATORIES LUPIN LTD/
DIVIS LABORATORIES
 
P/E (TTM) x 134.2 35.1 382.8% View Chart
P/BV x 2.5 5.7 44.0% View Chart
Dividend Yield % 1.0 0.9 115.0%  

Financials

 LUPIN LTD   DIVIS LABORATORIES
EQUITY SHARE DATA
    LUPIN LTD
Mar-17
DIVIS LABORATORIES
Mar-17
LUPIN LTD/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,7501,222 143.2%   
Low Rs1,384784 176.5%   
Sales per share (Unadj.) Rs387.4153.1 253.0%  
Earnings per share (Unadj.) Rs56.639.9 141.8%  
Cash flow per share (Unadj.) Rs76.844.6 172.3%  
Dividends per share (Unadj.) Rs7.5010.00 75.0%  
Dividend yield (eoy) %0.51.0 48.0%  
Book value per share (Unadj.) Rs298.9201.8 148.1%  
Shares outstanding (eoy) m451.58265.47 170.1%   
Bonus/Rights/Conversions ESOPS--  
Price / Sales ratio x4.06.6 61.7%   
Avg P/E ratio x27.725.1 110.2%  
P/CF ratio (eoy) x20.422.5 90.7%  
Price / Book Value ratio x5.25.0 105.5%  
Dividend payout %13.225.0 52.9%   
Avg Mkt Cap Rs m707,513266,266 265.7%   
No. of employees `00016.89.7 172.5%   
Total wages/salary Rs m28,4954,687 607.9%   
Avg. sales/employee Rs Th10,418.34,175.0 249.5%   
Avg. wages/employee Rs Th1,697.0481.5 352.4%   
Avg. net profit/employee Rs Th1,523.01,089.3 139.8%   
INCOME DATA
Net Sales Rs m174,94340,643 430.4%  
Other income Rs m1,065749 142.2%   
Total revenues Rs m176,00841,392 425.2%   
Gross profit Rs m44,93114,460 310.7%  
Depreciation Rs m9,1221,233 739.7%   
Interest Rs m1,52523 6,749.1%   
Profit before tax Rs m35,34913,953 253.3%   
Minority Interest Rs m-720-   
Prior Period Items Rs m830-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,7853,349 292.2%   
Profit after tax Rs m25,57510,604 241.2%  
Gross profit margin %25.735.6 72.2%  
Effective tax rate %27.724.0 115.3%   
Net profit margin %14.626.1 56.0%  
BALANCE SHEET DATA
Current assets Rs m119,54240,105 298.1%   
Current liabilities Rs m61,2066,595 928.1%   
Net working cap to sales %33.382.5 40.4%  
Current ratio x2.06.1 32.1%  
Inventory Days Days76119 64.1%  
Debtors Days Days9081 111.4%  
Net fixed assets Rs m131,66019,995 658.5%   
Share capital Rs m903531 170.1%   
"Free" reserves Rs m134,07353,043 252.8%   
Net worth Rs m134,97653,574 251.9%   
Long term debt Rs m56,4780-   
Total assets Rs m266,07361,585 432.0%  
Interest coverage x24.2618.4 3.9%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.70.7 99.6%   
Return on assets %10.217.3 59.0%  
Return on equity %18.919.8 95.7%  
Return on capital %19.326.1 73.9%  
Exports to sales %00-   
Imports to sales %025.2 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA10,259 0.0%   
Fx inflow Rs m81,88535,384 231.4%   
Fx outflow Rs m21,50610,399 206.8%   
Net fx Rs m60,37824,985 241.7%   
CASH FLOW
From Operations Rs m41,14811,493 358.0%  
From Investments Rs m-25,287-11,372 222.4%  
From Financial Activity Rs m4,332-93 -4,652.8%  
Net Cashflow Rs m20,19328 71,100.4%  

Share Holding

Indian Promoters % 46.6 52.0 89.6%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 11.8 95.8%  
FIIs % 31.9 19.0 167.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 17.2 58.7%  
Shareholders   98,259 31,796 309.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN LTD With:   SUVEN LIFE  SHASUN PHARMA  PFIZER  TTK HEALTHCARE  SUN PHARMA  

Compare LUPIN LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Up; ONGC & Tata Steel Top Gainers(Closing)

Indian share markets ended the day on a strong note. At the closing bell, the BSE Sensex finished higher by 262 points. While, the NSE Nifty finished up by 91 points.

Related Views on News

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


May 25, 2018 (Close)

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE LUPIN LTD WITH

MARKET STATS